Literature DB >> 14726463

History, dynamics, and public health importance of malaria parasite resistance.

Ambrose O Talisuna1, Peter Bloland, Umberto D'Alessandro.   

Abstract

Despite considerable efforts, malaria is still one of the most devastating infectious diseases in the tropics. The rapid spread of antimalarial drug resistance currently compounds this grim picture. In this paper, we review the history of antimalarial drug resistance and the methods for monitoring it and assess the current magnitude and burden of parasite resistance to two commonly used drugs: chloroquine and sulfadoxine-pyrimethamine. Furthermore, we review the factors involved in the emergence and spread of drug resistance and highlight its public health importance. Finally, we discuss ways of dealing with such a problem by using combination therapy and suggest some of the research themes needing urgent answers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726463      PMCID: PMC321461          DOI: 10.1128/CMR.17.1.235-254.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  224 in total

1.  Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria.

Authors:  A Djimdé; O K Doumbo; R W Steketee; C V Plowe
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

2.  Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.

Authors:  M R Kamya; N N Bakyaita; A O Talisuna; W M Were; S G Staedke
Journal:  Trop Med Int Health       Date:  2002-12       Impact factor: 2.622

3.  Field research, relief work and war: does chloroquine-resistance occur in displaced populations of southern Sudan?

Authors:  J P Guthmann; C Cètre; F Suzan; S Darovare; F Morin
Journal:  Trop Doct       Date:  1996-04       Impact factor: 0.731

4.  Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy.

Authors:  C V Plowe; O K Doumbo; A Djimde; K Kayentao; Y Diourte; S N Doumbo; D Coulibaly; M Thera; T E Wellems; D A Diallo
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

5.  A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

Authors:  P Druilhe; A Moreno; C Blanc; P H Brasseur; P Jacquier
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

6.  Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.

Authors:  J K Baird; M F Sustriayu Nalim; H Basri; S Masbar; B Leksana; E Tjitra; R M Dewi; M Khairani; F S Wignall
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jul-Aug       Impact factor: 2.184

Review 7.  Artemisinin derivatives for treating uncomplicated malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.

Authors:  A M Nzila; E K Mberu; J Sulo; H Dayo; P A Winstanley; C H Sibley; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 9.  Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review.

Authors:  H M McIntosh; B M Greenwood
Journal:  Ann Trop Med Parasitol       Date:  1998-04

10.  Chloroquine for the treatment of uncomplicated malaria in Guyana.

Authors:  J K Baird; T Tiwari; G J Martin; C L Tamminga; T M Prout; J Tjaden; P P Bravet; S Rawlins; M Ferrel; D Carucci; S L Hoffman
Journal:  Ann Trop Med Parasitol       Date:  2002-06
View more
  93 in total

Review 1.  The changing limits and incidence of malaria in Africa: 1939-2009.

Authors:  Robert W Snow; Punam Amratia; Caroline W Kabaria; Abdisalan M Noor; Kevin Marsh
Journal:  Adv Parasitol       Date:  2012       Impact factor: 3.870

Review 2.  Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.

Authors:  Naman K Shah; Gajender P S Dhillon; Adtiya P Dash; Usha Arora; Steven R Meshnick; Neena Valecha
Journal:  Lancet Infect Dis       Date:  2011-01       Impact factor: 25.071

Review 3.  Target assessment for antiparasitic drug discovery.

Authors:  Julie A Frearson; Paul G Wyatt; Ian H Gilbert; Alan H Fairlamb
Journal:  Trends Parasitol       Date:  2007-10-24

4.  Benefits of using multiple first-line therapies against malaria.

Authors:  Maciej F Boni; David L Smith; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

5.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

Review 6.  Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

Authors:  Ambrose O Talisuna; Corine Karema; Bernhards Ogutu; Elizabeth Juma; John Logedi; Andrew Nyandigisi; Modest Mulenga; Wilfred F Mbacham; Cally Roper; Philippe J Guerin; Umberto D'Alessandro; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2012-11       Impact factor: 25.071

Review 7.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

8.  Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

9.  Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.

Authors:  Quique Bassat; Modest Mulenga; Halidou Tinto; Patrice Piola; Steffen Borrmann; Clara Menéndez; Michael Nambozi; Innocent Valéa; Carolyn Nabasumba; Philip Sasi; Antonella Bacchieri; Marco Corsi; David Ubben; Ambrose Talisuna; Umberto D'Alessandro
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

10.  Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.

Authors:  Alain Nahum; Annette Erhart; Daniel Ahounou; Désiré Bonou; Chantal Van Overmeir; Joris Menten; Martin Akogbeto; Marc Coosemans; Achille Massougbodji; Umberto D'Alessandro
Journal:  Malar J       Date:  2009-03-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.